April 8, PharmAust Receives $750k R&D Tax Incentive Refund
210308_750K R&D TAX Return
April 7, LUMC: Monepantel Testing Indicates Anti-Covid19 Activity
210407_LUMC_Covid19_Testing
March 31, Top 20 Shareholders
210331_Top_Holders_Report – 2021-04-01T101952.158
March 31, Monepantel Phase IIb Dog Lymphoma Trial Update
210331_PhaseIIb Trial Update
March 23, Epichem Waste to Fuel Licensing Agreement with Thermaquatica
210323_PAA_Epichem_Thermaquatica
February 28, Top 20 Shareholders
200301_Top_Holders_Report
February 26, Appendix 4D & Half Year Report
210226_Appendix 4D, half yearly report
February 15, Canine Monepantel Phase IIb Lymphoma Trial Update
210215_PhaseIIb_update
February 10, LUMC Covid-19 Research Update
210210_LUMC_Update
January 31, Top 20 Shareholders
210131_Top20Shareholders